RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @KaminskiMed: Agreed! https://t.co/LyJygXKeDR
Agreed!
RT @fritsfranssen: Aspirin to reduce COPD exacerbations? Following statins and beta-blockers, probably the next negative RCT in a major jou…
RT @fritsfranssen: Aspirin to reduce COPD exacerbations? Following statins and beta-blockers, probably the next negative RCT in a major jou…
RT @fritsfranssen: Aspirin to reduce COPD exacerbations? Following statins and beta-blockers, probably the next negative RCT in a major jou…
RT @fritsfranssen: Aspirin to reduce COPD exacerbations? Following statins and beta-blockers, probably the next negative RCT in a major jou…
RT @fritsfranssen: Aspirin to reduce COPD exacerbations? Following statins and beta-blockers, probably the next negative RCT in a major jou…
RT @fritsfranssen: Aspirin to reduce COPD exacerbations? Following statins and beta-blockers, probably the next negative RCT in a major jou…
Aspirin to reduce COPD exacerbations? Following statins and beta-blockers, probably the next negative RCT in a major journal next year. https://t.co/4aY30Wlkcd @accpchest https://t.co/08Dptxu5VM
RT @AshFawzyMD: Check out my latest publication in @accpchest showing that #aspirin use was associated with fewer #COPD exacerbations, bett…
RT @AshFawzyMD: Check out my latest publication in @accpchest showing that #aspirin use was associated with fewer #COPD exacerbations, bett…
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @COPDCanada: Aspirin Use and Respiratory Morbidity in COPD https://t.co/EAigzlkOrg
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
Aspirin Use and Respiratory Morbidity in COPD https://t.co/EAigzlkOrg
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
Aspirin Use and Respiratory Morbidity in COPD https://t.co/mJprv38u04
La aspirina como medicamento base para reducir los episodios de exacerbación , disnea y mejora la calidad de vida https://t.co/VZ9tnQhh4V
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
Daily aspirin use may also increase the risk of bleeding. Tough for internist to balance pros and cons #Medicine
A la madre!!!!
Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/JQPN1j2O61
RT @AngelAzpeitia: @AdolfoBaloira Interesante Adolfo. Añado el link https://t.co/gP3lrahu7c Ya lo planteaba Don Sin en 2014 en un editoria…
RT @ATS_BSHSR: Aspirin Use and #Respiratory Morbidity in #COPD: a Propensity Score Matched Analysis in SPIROMICS #pulmonary #lung https://t…
RT @AngelAzpeitia: @AdolfoBaloira Interesante Adolfo. Añado el link https://t.co/gP3lrahu7c Ya lo planteaba Don Sin en 2014 en un editoria…
RT @AngelAzpeitia: @AdolfoBaloira Interesante Adolfo. Añado el link https://t.co/gP3lrahu7c Ya lo planteaba Don Sin en 2014 en un editoria…
RT @AngelAzpeitia: @AdolfoBaloira Interesante Adolfo. Añado el link https://t.co/gP3lrahu7c Ya lo planteaba Don Sin en 2014 en un editoria…
@AdolfoBaloira Interesante Adolfo. Añado el link https://t.co/gP3lrahu7c Ya lo planteaba Don Sin en 2014 en un editorial de Thorax https://t.co/bpRKMFzJzk
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @respiratorydec: #aspirin can reduce rate of #COPD #exacerbations https://t.co/ezpnGwHp4v
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @respiratorydec: #aspirin can reduce rate of #COPD #exacerbations https://t.co/ezpnGwHp4v
#aspirin can reduce rate of #COPD #exacerbations
Aspirin Use and Respiratory Morbidity in COPD https://t.co/EhP7xOSbIL
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @JHUPCCMFellows: Congrats!! To Drs. Fawzy, Putcha, Krishnan, Paulin, Wise and Hansel!! On their recent publication on aspirin use and CO…
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
Congrats!! To Drs. Fawzy, Putcha, Krishnan, Paulin, Wise and Hansel!! On their recent publication on aspirin use and COPD!! #HopkinsPCCMFellowship #HopkinsPCCM #HopkinsPCCMFellowshipAlum https://t.co/ImaSTV9rjP
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
RT @accpchest: Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
Daily aspirin use found to be associated with lower rates of #COPD exacerbation. #journalCHEST https://t.co/reA34b9bqC
Aspirin Use and Respiratory Morbidity in COPD https://t.co/qE06ttgLf2
アスピリンの使用はCOPD急性増悪のリスク減少と関連するかも。Chest. 2019; 155: 519 PMID: 30593776 https://t.co/F3Q7019Ldd
RT @ATS_EOPH: Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome…
RT @ATS_EOPH: Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome…
RT @ATS_EOPH: Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome…
RT @ATS_EOPH: Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome…
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study (Chest. 2018 Dec 26. pii: S0012-3692(18)32887-3). https://t.co/t3CwzYaTnz
O uso diário de aspirina está associado à redução da taxa de exacerbações da DPOC, menos dispneia e melhor qualidade de vida. https://t.co/hbB1Zn9FtF
RT @LachowiczMarrah: Aspirin seems to have additional benefits for the lung by reducing exacerbations in COPD. Dose information was not ava…
RT @LachowiczMarrah: Aspirin seems to have additional benefits for the lung by reducing exacerbations in COPD. Dose information was not ava…
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @LachowiczMarrah: Aspirin seems to have additional benefits for the lung by reducing exacerbations in COPD. Dose information was not ava…
RT @LachowiczMarrah: Aspirin seems to have additional benefits for the lung by reducing exacerbations in COPD. Dose information was not ava…
RT @LachowiczMarrah: Aspirin seems to have additional benefits for the lung by reducing exacerbations in COPD. Dose information was not ava…
Aspirin seems to have additional benefits for the lung by reducing exacerbations in COPD. Dose information was not available, low-dose aspirin use may be common in this population, 81 mg a day.
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @Epocrates: Can an aspirin a day improve COPD outcomes? via @accpchest https://t.co/AI6e7MrOjs https://t.co/RtSY0M8FT1
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @ProfAnestesista: #Aspirin Use and Respiratory Morbidity in #COPD @accpchest | #ECM https://t.co/VK9gF9S3fU
#Aspirin Use and Respiratory Morbidity in #COPD @accpchest | #ECM https://t.co/VK9gF9S3fU
#LectureDeLaSemaine L'aspirine préventive a-t-elle un effet sur les évènements pneumologiques de patients BPCO? https://t.co/vQkSQOOIkk
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @ATS_BSHSR: Aspirin Use and #Respiratory Morbidity in #COPD: a Propensity Score Matched Analysis in SPIROMICS #pulmonary #lung https://t…
RT @ATS_BSHSR: Aspirin Use and #Respiratory Morbidity in #COPD: a Propensity Score Matched Analysis in SPIROMICS #pulmonary #lung https://t…
Aspirin Use and #Respiratory Morbidity in #COPD: a Propensity Score Matched Analysis in SPIROMICS #pulmonary #lung https://t.co/eRm9c7szU6 https://t.co/qz2Hx23Wlx
#Aspirin Use and Respiratory Morbidity in #COPD @accpchest https://t.co/tYIJ6X4AH7
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
RT @atscommunity: Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi
Aspirin use and respiratory morbidity in #COPD: https://t.co/Nzhy0nIDWi